Cargando…

Obesity, Metabolic Syndrome and Risk of Atrial Fibrillation: A Swedish, Prospective Cohort Study

AIM: We aimed to investigate whether different measures of obesity could similarly predict atrial fibrillation, and whether the atrial fibrillation risk associated with obesity is dependent on presence of metabolic syndrome. MATERIAL AND METHODS: We performed our study in a population-based longitud...

Descripción completa

Detalles Bibliográficos
Autores principales: Nyström, Petter K., Carlsson, Axel C., Leander, Karin, de Faire, Ulf, Hellenius, Mai-Lis, Gigante, Bruna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433194/
https://www.ncbi.nlm.nih.gov/pubmed/25978738
http://dx.doi.org/10.1371/journal.pone.0127111
_version_ 1782371599023865856
author Nyström, Petter K.
Carlsson, Axel C.
Leander, Karin
de Faire, Ulf
Hellenius, Mai-Lis
Gigante, Bruna
author_facet Nyström, Petter K.
Carlsson, Axel C.
Leander, Karin
de Faire, Ulf
Hellenius, Mai-Lis
Gigante, Bruna
author_sort Nyström, Petter K.
collection PubMed
description AIM: We aimed to investigate whether different measures of obesity could similarly predict atrial fibrillation, and whether the atrial fibrillation risk associated with obesity is dependent on presence of metabolic syndrome. MATERIAL AND METHODS: We performed our study in a population-based longitudinal cardiovascular study, comprising 1 924 men and 2 097 women, aged 60 years, from Stockholm. Body mass index, waist circumference, sagittal abdominal diameter and components of metabolic syndrome (systolic- and diastolic blood pressure, fasting glucose, triglycerides, high-density lipoprotein-cholesterol) were recorded at baseline. Participants were classified by their body mass index (normal weight, overweight or obese), waist circumference (normal, semi-elevated or elevated), and according to presence of metabolic syndrome. Atrial fibrillation risk was estimated by Cox proportional hazards regression models, adjusted for common atrial fibrillation risk factors, expressed as HR and 95% CI. RESULTS: During a mean follow-up of 13.6 years, 285 incident atrial fibrillation cases were recorded. One standard deviation increment of each obesity measure was associated with increased atrial fibrillation risk as: body mass index 1.25 (1.12 – 1.40), waist circumference 1.35 (1.19 – 1.54) and sagittal abdominal diameter 1.28 (1.14 – 1.44). Compared to normal weight subjects without metabolic syndrome, increased atrial fibrillation risk was noted for overweight subjects with metabolic syndrome, 1.67 (1.16 – 2.41), obese subjects without metabolic syndrome, 1.75 (1.11 – 2.74) and obese subjects with metabolic syndrome, 1.92 (1.34 – 2.74). Compared to subjects with normal waist circumference without metabolic syndrome, subjects with elevated waist circumference and metabolic syndrome suffered increased atrial fibrillation risk, 2.03 (1.44 – 2.87). CONCLUSIONS: Body mass index, waist circumference and sagittal abdominal diameter could similarly predict atrial fibrillation. Obesity was associated with an increased atrial fibrillation risk regardless of metabolic syndrome, whereas overweight and elevated waist circumference was associated with increased atrial fibrillation risk only if metabolic syndrome was present.
format Online
Article
Text
id pubmed-4433194
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-44331942015-05-27 Obesity, Metabolic Syndrome and Risk of Atrial Fibrillation: A Swedish, Prospective Cohort Study Nyström, Petter K. Carlsson, Axel C. Leander, Karin de Faire, Ulf Hellenius, Mai-Lis Gigante, Bruna PLoS One Research Article AIM: We aimed to investigate whether different measures of obesity could similarly predict atrial fibrillation, and whether the atrial fibrillation risk associated with obesity is dependent on presence of metabolic syndrome. MATERIAL AND METHODS: We performed our study in a population-based longitudinal cardiovascular study, comprising 1 924 men and 2 097 women, aged 60 years, from Stockholm. Body mass index, waist circumference, sagittal abdominal diameter and components of metabolic syndrome (systolic- and diastolic blood pressure, fasting glucose, triglycerides, high-density lipoprotein-cholesterol) were recorded at baseline. Participants were classified by their body mass index (normal weight, overweight or obese), waist circumference (normal, semi-elevated or elevated), and according to presence of metabolic syndrome. Atrial fibrillation risk was estimated by Cox proportional hazards regression models, adjusted for common atrial fibrillation risk factors, expressed as HR and 95% CI. RESULTS: During a mean follow-up of 13.6 years, 285 incident atrial fibrillation cases were recorded. One standard deviation increment of each obesity measure was associated with increased atrial fibrillation risk as: body mass index 1.25 (1.12 – 1.40), waist circumference 1.35 (1.19 – 1.54) and sagittal abdominal diameter 1.28 (1.14 – 1.44). Compared to normal weight subjects without metabolic syndrome, increased atrial fibrillation risk was noted for overweight subjects with metabolic syndrome, 1.67 (1.16 – 2.41), obese subjects without metabolic syndrome, 1.75 (1.11 – 2.74) and obese subjects with metabolic syndrome, 1.92 (1.34 – 2.74). Compared to subjects with normal waist circumference without metabolic syndrome, subjects with elevated waist circumference and metabolic syndrome suffered increased atrial fibrillation risk, 2.03 (1.44 – 2.87). CONCLUSIONS: Body mass index, waist circumference and sagittal abdominal diameter could similarly predict atrial fibrillation. Obesity was associated with an increased atrial fibrillation risk regardless of metabolic syndrome, whereas overweight and elevated waist circumference was associated with increased atrial fibrillation risk only if metabolic syndrome was present. Public Library of Science 2015-05-15 /pmc/articles/PMC4433194/ /pubmed/25978738 http://dx.doi.org/10.1371/journal.pone.0127111 Text en © 2015 Nyström et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Nyström, Petter K.
Carlsson, Axel C.
Leander, Karin
de Faire, Ulf
Hellenius, Mai-Lis
Gigante, Bruna
Obesity, Metabolic Syndrome and Risk of Atrial Fibrillation: A Swedish, Prospective Cohort Study
title Obesity, Metabolic Syndrome and Risk of Atrial Fibrillation: A Swedish, Prospective Cohort Study
title_full Obesity, Metabolic Syndrome and Risk of Atrial Fibrillation: A Swedish, Prospective Cohort Study
title_fullStr Obesity, Metabolic Syndrome and Risk of Atrial Fibrillation: A Swedish, Prospective Cohort Study
title_full_unstemmed Obesity, Metabolic Syndrome and Risk of Atrial Fibrillation: A Swedish, Prospective Cohort Study
title_short Obesity, Metabolic Syndrome and Risk of Atrial Fibrillation: A Swedish, Prospective Cohort Study
title_sort obesity, metabolic syndrome and risk of atrial fibrillation: a swedish, prospective cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433194/
https://www.ncbi.nlm.nih.gov/pubmed/25978738
http://dx.doi.org/10.1371/journal.pone.0127111
work_keys_str_mv AT nystrompetterk obesitymetabolicsyndromeandriskofatrialfibrillationaswedishprospectivecohortstudy
AT carlssonaxelc obesitymetabolicsyndromeandriskofatrialfibrillationaswedishprospectivecohortstudy
AT leanderkarin obesitymetabolicsyndromeandriskofatrialfibrillationaswedishprospectivecohortstudy
AT defaireulf obesitymetabolicsyndromeandriskofatrialfibrillationaswedishprospectivecohortstudy
AT helleniusmailis obesitymetabolicsyndromeandriskofatrialfibrillationaswedishprospectivecohortstudy
AT gigantebruna obesitymetabolicsyndromeandriskofatrialfibrillationaswedishprospectivecohortstudy